SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is seeing intense speculation and polarized debate as investors brace for upcoming earnings, with the community closely tracking indicators of AI-driven commercial demand and sovereign contract growth. Market participants are split between bullish sentiment fueled by potential revenue acceleration and skeptical outlooks regarding the stock's premium valuation and the sustainability of its AI-related expansion.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following the announcement of a private exchange of debt for equity, a move that has sparked intense debate among investors regarding the balance between long-term debt reduction and immediate shareholder dilution. The community remains deeply divided, with some viewing the move as a strategic cleanup of the balance sheet ahead of potential acquisitions, while others express frustration over the impact on share price and management's capital allocation decisions.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending as investors weigh heavy skepticism toward its leadership and share structure against speculative optimism surrounding upcoming AI/AR smart glasses and potential monetization improvements. While the community remains deeply divided over the CEOs management and persistent lawsuits, the stock is seeing significant options activity and bullish speculation ahead of its next earnings release.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is surging following a 10-3 vote from an FDA advisory committee that deemed its lead melanoma drug's efficacy results clinically meaningful, despite prior regulatory setbacks. The community is heavily focused on the impending PDUFA decision while debating whether the positive panel outcome is enough to overcome previous data concerns or if it remains a risky setup for a potential third rejection.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing significant selling pressure and volatility as traders weigh negative sentiment regarding margin pressure against strong underlying growth and acquisition-driven expansion. The community is sharply divided, with bulls viewing the current price as a generational buying opportunity ahead of upcoming earnings, while skeptics point to intense market competition and technical weakness as reasons to remain cautious.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors intensely monitor the anticipated 80th event data release and potential buyout rumors, fueling a clash between long-term bulls and skeptical short-sellers. Community discussion is focused on the impact of a possible quiet period and the looming top-line Phase 3 trial results, which many view as a critical catalyst for the stock's future valuation.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Investors are actively debating Luckin Coffee's long-term growth potential and store expansion strategy in the U.S. and China, while closely monitoring upcoming earnings reports for catalysts that could trigger a price breakout. Sentiment remains polarized between long-term holders confident in the company's fundamentals and those concerned about market volatility, OTC listing status, and the ongoing competitive landscape.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is experiencing a significant sell-off following an earnings release that, while beating revenue expectations and raising full-year guidance, resulted in an EPS miss driven by reinvestment in clinical pipeline growth. Shareholders are currently debating whether the sharp price decline represents a manufactured short attack or a standard market reaction to earnings-related volatility, with many long-term investors highlighting strong commercial execution and the potential for a future acquisition as reasons to maintain their positions.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing intense volatility as the community remains deeply divided over its status as a defensive value play versus a fundamentally broken brand, with high-conviction bears aggressively shorting the stock ahead of upcoming earnings. Traders are closely monitoring the stock's struggle to hold key support levels, with heated debates centered on whether menu pricing, consumer slowdowns, and potential health-related supply chain concerns justify a deeper sell-off.

Blue Owl Capital, Inc. operates as an alternative asset management firm. It provides investors access to asset management capital solutions through its Direct Lending and GP Capital Solutions products. The company offers a platform of capital solutions to both middle market companies and large alternative asset managers. The company was founded by Doug Irving Ostrover, Michael Rees and Craig W.Packer in 2009 and is headquartered in New York, NY.

Blue Owl Capital Inc - Ordinary Shares - Class A

Blue Owl Capital is trending as investors digest news of successful bond offerings and ongoing fundraising activity, which the community sees as a rebuttal to bearish private credit narratives and liquidity concerns. Despite persistent volatility and negative media sentiment regarding redemption pressures, many investors are focused on the firm's long-term growth in data center infrastructure and underlying portfolio stability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

3 High-Quality Dividend Growth ETFs Beating the S&P 500

These ETFs invest in high-quality companies while reducing AI concentration risk.

Dividend ETF (SDY) Hits a New 52-Week High

SDY hits a 52-week high as market uncertainty strengthens the appeal of dividend stocks.

Should State Street SPDR S&P Dividend ETF (SDY) Be on Your Investing Radar?

The Zacks Analyst Blog Highlights SDY, NOBL, OUSA, PFM, PEY and SNPD

Dividend Aristocrat ETFs are in focus as investors seek income, stability and long histories of dividend growth amid market volatility.

Guide to Dividend Aristocrat ETF Investing

Dividend Aristocrats ETFs offer steady income, dividend growth and downside protection, making them ideal picks for navigating volatile markets.



Is State Street SPDR S&P Dividend ETF (SDY) a Strong ETF Right Now?

The Zacks Analyst Blog  SDY, NOBL, OUSA and PFM

Amid oil-driven volatility and inflation worries, dividend aristocrat ETFs like NOBL draw attention as investors seek steady income and resilient equity exposure.

Play Dividend Growth ETFs With a Long-Term View 

Oil turmoil, inflation worries and market volatility are reviving interest in dividend growth ETFs that offer steady income and quality exposure.

SPDR Series Trust - State Street SPDR S&P Dividend ETF

T. Rowe Price Stock Falls After Q4 Profit Miss: Retail Turns Extremely Bearish

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$155.90
Prev Close	$155.00
Open	$156.72
Dividend Yield	N/A
50-Day Moving Average	$152.36
Beta	N/A
Avg. Volume	251,344.02
PE Ratio	N/A

52-Week High	$160.29
52-Week Low	$135.30
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info